![](/images/2013/post-sep.jpg)
Tumor Ablation Market Global Industry Growth Prospects and Opportunity Assessment by 2032
![The global tumor ablation market size was USD 1](https://img.einnews.com/ampsize/236345/emergen-research.png)
Increasing prevalence of cancer and technological advancements in tumor ablation are key factors driving market revenue growth.
VANCOUVER, BRITISH COLUMBIA, CANADA, June 28, 2024 /EINPresswire.com/ -- The global tumor ablation market size was USD 1.68 Billion in 2022 and is expected to register a rapid revenue CAGR of 13.6% during the forecast period. The global tumor ablation market is experiencing significant growth, driven by increasing cancer prevalence and advancements in treatment technologies, according to a recent market research report.
Tumor ablation devices are crucial in treating tumors where surgery may not be suitable or when patients opt for minimally invasive alternatives. Cancer remains a leading cause of death worldwide, with the World Health Organization estimating 10 million deaths attributed to the disease in 2020 alone.
Download Free Exclusive Sample PDF@ https://www.emergenresearch.com/request-sample/2680
Key Factors Driving Market Growth:
Technological Advancements: Innovations such as AI-powered ablation systems are enhancing treatment accuracy and efficacy. These systems utilize AI to identify and target tumors, offering personalized treatment plans based on individual patient characteristics.
Rising Demand for Minimally Invasive Procedures: Procedures like radiofrequency (RF) ablation and microwave ablation (MWA) are preferred for their smaller incisions, reduced pain, and faster recovery times compared to traditional surgical methods.
Government Approvals and Product Launches: Increasing approvals by regulatory bodies for advanced ablation technologies are further propelling market growth. Recent examples include Stryker's optablate bone tumor ablation system and HistoSonics' Edison system for liver tumors.
Market Challenges: Despite growth opportunities, the market faces challenges such as competition from alternative treatments like surgery and radiation therapy, which offer comparable effectiveness in certain cases.
Market Segment Insights:
Technology Segmentation: RF ablation currently dominates the market due to its effectiveness and widespread adoption. However, microwave ablation is projected to grow rapidly, particularly in treating liver, kidney, and lung cancers.
Application Segmentation: Liver cancer treatment holds a significant market share, driven by its high prevalence globally. The lung cancer segment is also growing steadily due to rising incidence rates and technological advancements in minimally invasive procedures.
Treatment Methods: Percutaneous ablation, which involves thin needles inserted through the skin guided by imaging technologies, is the leading treatment method. It offers advantages such as minimal scarring, faster recovery, and lower costs compared to surgical alternatives.
End-Use Insights: Hospitals are the primary end-users, benefiting from access to advanced treatment options and comprehensive patient care facilities.
Get An Impressive Discount On This Report@ https://www.emergenresearch.com/request-discount/2680
Some major players included in the global tumor ablation market report are:
Medtronic
Stryker Corporation
Boston scientific Corporation
OLYMPUS Corporation
BIOTRONIK
Angio Dynamics
Johnson and Johnson Private limited
Theraclion
EDAP TMS
Merit Medical Systems
Tumor Ablation Latest Industry News
On 30 March 2023, AngioDynamics announced that it has formed a new partnership with Minimax Medical for international distribution of their product portfolio. This also includes distribution of Radiofrequency Ablation System for tumors on an international level. The partnership increases AngioDynamics' reach into new markets by giving access to a wider pool of potential customers and an enhanced product portfolio.
On 19 December 2022, Techsomed Ltd. announced the opening of a new German Subsidiary, as a strategic collaboration with Research Institute Fraunhofer MEVIS, to advance the development of its flagship software technology BioTraceIO 360. This is an End-to-End Solution for Image-Guided Tumor Ablation Therapy. This announcement adds Techsomed’s lineup by eliminating the need for invasive biopsies and providing real-time guidance during ablation procedures.
Tumor Ablation Market Segment Analysis
For the purpose of this report, Emergen Research has segmented the global tumor ablation market on the basis of technology, application, treatment, end-use, and region:
Technology outlook (Revenue, USD Billion; 2019-2032)
Radiofrequency Ablation
Microwave Ablation
Ultrasound Ablation
Cryoablation
Others
Application Outlook (Revenue, USD Billion; 2019-2032)
Lung Cancer
Lung Cancer
Prostate Cancer
Breast Cancer
Kidney Cancer
Others
Treatment Outlook (Revenue, USD Billion; 2019-2032)
Percutaneous Ablation
Laparoscopic Ablation
Surgical Ablation
End-use Outlook (Revenue, USD Billion; 2019-2032)
Hospitals
Oncology Centers
Ambulatory Surgical Center (ASC)
Regional Outlook (Revenue, USD Billion; 2019–2032)
North America
U.S.
Canada
Europe
Germany
France
UK
Italy
Spain
Benelux
Russia
Rest of Europe
Asia Pacific
China
Japan
South Korea
India
ASEAN Countries
Oceania
Rest of APAC
Latin America
Brazil
Mexico
Rest of LATAM
Middle East & Africa
GCC Countries
Israel
Turkey
South Africa
Rest of Middle East & Africa
Acquire the complete research report on the Global Market@ https://www.emergenresearch.com/industry-report/tumor-ablation-market
Look Over transcripts provided by Emergen Research
Insulation Monitoring Devices Market
https://www.emergenresearch.com/industry-report/insulation-monitoring-devices-market
Low Carbon Glass Market
https://www.emergenresearch.com/industry-report/low-carbon-glass-market
Laser Processing Market
https://www.emergenresearch.com/industry-report/laser-processing-market
Absorbable Antibacterial Envelope Market
https://www.emergenresearch.com/industry-report/absorbable-antibacterial-envelope-market
Advanced Automotive Suspensions Market
https://www.emergenresearch.com/industry-report/advanced-automotive-suspensions-market
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Eric Lee
Emergen Research
+91 90210 91709
sales@emergenresearch.com
Visit us on social media:
Facebook
X
LinkedIn
![](https://health.einnews.com/tracking/article.gif?aid=723666767§ion=einpresswire&a=xeO8Ikt0Gz9lQB2h&i=zELewFynuN3RqorZ)
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.